Abstract
Ferroptosis, a regulated non-apoptotic form of cell death, has been implicated in the response to varied types of infectious agents including virus. In this study, we sought to determine whether SARS-CoV-2 infection can induce activation of ferroptosis in the human placenta. We collected placentas from 23 pregnant females with laboratory-confirmed SARS-CoV-2 following delivery and then used RNA in situ hybridization assay for detection of viral positive-sense strand (PSS) to confirm that these placentas have been infected. We also used immunohistochemistry assay to assess expression levels of acyl-CoA synthetase long-chain family member 4 (ACSL4), an essential executioner of ferroptosis in the same specimens. Our results showed that ACSL4 expression was significantly increased in the group with positive positive-sense strand staining compared to their negative counterparts (p = 0.00022). Furthermore, we found that there was a positive trend for increased PSS staining along with increased ACSL4 expression. Our study supports that ferroptosis is activated in the response to SARS-CoV-2 infection in the human placenta, highlighting a molecular mechanism potentially linking this coronavirus infection and pathogenesis of adverse pregnancy outcomes.
Introduction
Pregnancy represents a distinctive immunological condition and the remarkable changes in levels of both hormones and immune cell-released cytokines may enhance pregnant females’ vulnerability to viral infection including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (). Indeed, pregnant females are at increased risk for such coronavirus infection, and in turn, worse outcomes of coronavirus disease 2019 (COVID-19) (). Multiple studies have reported higher rates of pregnancy-related complications, including preterm birth, preeclampsia, and stillbirth with SARS-CoV-2 infection during pregnancy (; ; ; ; ), warranting urgency to a pursuit of research into underlying molecular pathways leading to the pathogenesis of these adverse pregnancy outcomes and development of optimal COVID-19 treatment and preventive approaches during pregnancy.
The majority of adverse obstetrical consequences is embedded with a placental origin, which is associated with placental inflammation because of infectious or non-infectious causes (). The human placenta synthesizes a large and diverse number of hormones and cytokines that exert major influences on ovarian, uterine, mammary, and fetal physiology, and there is good evidence supporting that placental dysfunction plays a key role in contributing to these common interrelated disorders, which occur in approximately 10%–20% of pregnancies (). The spectrum of placental pathological findings in pregnant females with SARS-CoV-2 infection showed substantial variability, but typically including chronic histiocytic intervillositis and syncytiotrophoblast necrosis, a form of cell injury-caused premature cell death in living tissues due to autolysis ().
Recent advances in understanding cell death under both physiological and non-physiological conditions have witnessed a significant shift with recognition of the role of ferroptosis in the regulation of cell fate in response to oxidative stress (). Ferroptosis, a form of nonapoptotic programmed cell death, is characterized by redox-active iron-dependent hydroxy-peroxidation of polyunsaturated fatty acid (PUFA)-containing phospholipids and loss of lipid peroxidation repair capacity (). This unique form of lipotoxic cell death has been implicated in various human diseases, including heart and brain injury, cancer, asthma, and placental physiology (). Furthermore, a number of studies have indicated lipotoxicity at a remarkably elevated level during the pathophysiological course of major pregnancy-associated disorders such as preeclampsia, fetal growth restriction, and prematurity ().
There is an increasing body of evidence supporting that placental SARS-CoV-2 infection is tightly associated with adverse pregnancy outcomes. While there are varied types of qualitative and quantitative techniques including RT-PCR, immunological assay, and viral genome sequencing used to confirm its presence in the human tissues (), NICHD and Human Development SARS-CoV-2 Placental Infection Workshop have recently set up the criteria for determining placental SARS-CoV-2 infection with use of RNA in situ hybridization (RNA-ISH) to detect viral positive-sense strand (PSS) as the top approach defining the placental presence by SARS-CoV-2 virions ().
Iron overload in cells and tissues coupled with hyperferritinemia has been well documented in patients with severe SARS-CoV-2 infection (; ; ; ), suggesting that the dysregulation of iron metabolism may play an important role in contributing to the pathogenesis of COVID-19. Indeed, while iron constitutes an essential element for all living cells, extra iron can cause overproduction of reactive oxygen species and damage of cellular macromolecules including lipids, nucleic acids, and proteins, thus leading to ferroptosis and multiorgan failure (). In this study, we sought to investigate whether SARS-CoV-2 virus can infect human placenta from pregnant females tested positive for SARS-CoV-2 with use of RNA-ISH assay. Meanwhile, we employed immunohistochemical (IHC) staining assay to determine the placental abundance of acyl-CoA synthetase long-chain family member 4 (ACSL4), the key executioner of ferroptosis (; ; ). Finally, we analyzed correlation between PSS staining intensity and ACSL4 expression levels within the same specimens.
Materials and methods
Study patients
Patients with 18 years and older with laboratory-confirmed SARS-CoV-2 infection that delivered at University of Maryland Medical Center whose respective placental specimens have been sent for histological examination were included in the study. Patients with a history of adverse pregnancy outcomes, hypertension, diabetes, autoimmune diseases, and infectious diseases including human immunodeficiency virus and tuberculosis were excluded. Upon delivery, each placenta sample was coded with a 5-digital number. We also collected placentas from six normal patients tested negative for SARS-CoV-2 infection as the control. This study was approved by the Institutional Review Board of the University of Maryland, Baltimore, under the protocols HP-00091334 and HP-00100457.
RNA-ISH
We conducted RNA-ISH in formalin-fixed paraffin-embedded (FFPE) slides with the use of the RNAScope 2.5 HD Detection (RED) Kit (ACD, CA) according to the protocol provided by the manufacturer as well as described in our recent publication (; ). Briefly, after deparaffinization and antigen retrieval, the slides were hybridized with the 40-ZZ probe targeting positive-sense strand (PSS), V-SARS-CoV-2-S (Cat#: 854841, ACD) in the oven at 40°C for 2 h. We then washed the slides with one X Wash Buffer for 2 min twice. The remaining hybridization procedure at 40°C included: 1) Amp 1, 30 min; 2) Amp 2, 15 min; 3) Amp, 30 min; 4) Amp 4, 15 min; and 5) Amp 5, 30 min and 6) Amp 6, 15 min under room temperature. Subsequently, the signals were detected by incubating with a mixture of RED-B and RED-A at a ratio of 1:60 for 10 min at room temperature, followed by counterstaining in 50% hematoxylin for 2 min.
The RNA-ISH was quantified with the use of QuPath, open-source software for digital pathology image analysis (). The percentage of staining area by viral PSS RNA in the chorionic villi tissues, including syncytiotrophoblast, cytotrophoblast, and fetal blood vessels was normalized to nuclear hematoxylin staining intensity, and the mean was obtained from three random fields in the same cross-section. We set the overall scores ranging from 0 to four based on the percentage staining area. If the staining area is <0.1% the score was 0. Scores 1, 2, 3, and 4 was defined if the staining area percentage were ≥0.1 and <1%, ≥1 and <2%, ≥2 and <3%, ≥3%, respectively.
IHC staining
IHC staining was performed as described in our recent studies (; ). Briefly, following deparaffinization and antigen retrieval, FFPE slides were blocked in phosphate-buffered saline (PBS) containing 4% donkey serum and 0.2% Triton X-100 for 1 h at room temperature. Then FFPE slides were incubated with primary antibody to ACSL4 at a dilution of 1:250 (Abcam, MA) overnight at 4°C; the sections were washed with PBS three times and incubated with biotinylated secondary donkey anti-rabbit antibody (Vector Laboratories, CA) in PBS with 0.2% Triton X-100 at a dilution of 1:500 for 1 h. Sections were washed again, and the secondary antibodies were detected by use of a DAB detection kit (Vector Laboratories), followed by counterstaining in 50% hematoxylin for 2 min.
ACSL4 staining in IHC was quantified with use of ImageJ, an image processing program developed at National Institutes of Health (). The mean of percentage of staining area by ACSL4 protein in the chorionic villi tissues was acquired from three random fields. We set the overall scores from 0 to nine based on the percentage staining area of <0.1%, ≥0.1 and <1%, ≥1 and <2%, ≥2 and <3%, ≥3% and <4%, ≥4 and <5%, ≥5 and <6%, ≥6 and <7%, ≥7 and <8%, and ≥9%, respectively.
Statistical analysis
Quantitative comparisons of ACSL4 abundance between two groups were examined with the Mann-Whitney U test. We used the linear regression to analyze correlation between staining degree of PSS and ACSL4.
Results
ACSL4 expression increased in SARS-CoV-2-infected placenta compared to negative control
ACSL4 plays a critical role in induction of ferroptotic cell death in a variety of cell types including neurons, fibroblast, and vascular and immune cells (; ; ). By shaping the cellular lipidome, ACSL4 dictates cells’ sensitivity or resistance in response to ferroptosis. Enzymatically, ACSL4 catalyzes esterification of CoA to free fatty acids; subsequently, the formation of acyl-CoA induces oxidation and lipid biosynthesis of corresponding fatty acids.
The overview of this study design and results of placental SARS-CoV-2 infection are depicted in Figure 1A. We used RNAScope-based RNA-ISH assay for detection of PSS of this coronavirus, which provides the most rigorous evidence to define whether the placenta has been infected (). Among the 23 patients determined with positive staining of PSS in the placenta, there were a total of 16, 2, 4, and 1 cases that were scored at 1, 2, 3, and 4, respectively. We also used IHC to assess the expression levels of ACSL4 in the same specimens. The scores for ACSL4 expression in the positive PSS staining group ranged from 0 to 9, in contrast to only one weakly positive staining of ACSL4 detected in the negative control group. The nonparametric Mann-Whitney U test determines that there was a significant difference in ACSL4 expression existing between these two groups with a p-value of 0.00022 and z-score of 3.7 (Figure 1B).
FIGURE 1
Taken together, these results support that SARS-CoV-2 infection leads to activation of ferroptosis in the human placenta.
Staining profile of SARS-CoV-2 and ACSL4 in the human placenta
We found that PSS staining was predominantly localized within the outermost syncytial knots/syncytiotrophoblast layer within the chorionic villi tissues in all the positive cases, independent of their respective scoring, consistent with that the placental barrier constitutes the first line of defense to protect the fetus from maternal viral infection (Figures 2, 3). Furthermore, PSS staining was also detected in the discontinuous monolayer of cytotrophoblast in some cases, e.g. #30600 and #30615 (PSS score = 1), #30609 (PSS score = 2), and #30600 (PSS score = 3), suggesting that this viral infection has crossed the placental barrier. Noticeably, in #30738 (PSS score = 4), fetal blood vessels demonstrated an exceedingly strong PSS staining, and our recent study has confirmed that this is the case of transplacental vertical transmission ().
FIGURE 2
FIGURE 3
Consistent with the results of PSS staining as described above, ACSL4 expression was primarily observed in the syncytiotrophoblast with some staining detected in cytotrophoblast at varying extents (Figures 2, 3).
Combined with the data showing that no significantly positive staining of either PSS or ACSL4 was observed in all six negative cases (Figure 4), these results further support that SARS-CoV-2 is a potent inducer for activation of ferroptosis in the human placenta.
FIGURE 4
A positive trend between SARS-CoV-2 infection degree and ACSL4 expression levels
Despite no significance observed, a linear regression analysis showed a positive trend (y = 1.0531x +4.2212, R2 = 0.1234) of increased scoring of PSS staining along with increased ACSL4 expression levels (Figure 5).
FIGURE 5
Discussion
The findings of this study are twofold. On the one hand, we used RNAScope-based RNA-ISH assay, a newly developed ISH platform, which has been extensively used for the detection of viral infection in vertebrate tissues (; ; ), to examine the PSS abundance in placentas collected from pregnant females tested positive for SARS-CoV-2 infection. The strengths of the RNAScope ISH platform primarily result from its unique double-Z probe design, which permits a superior background control with much less nonspecific hybridization (). We found that 23 specimens demonstrated a convincingly positive staining of PSS in placental chorionic villi tissues including syncytitrophoblast, cytotrophoblast, and fetal blood vessels to varying extents, in contrast to all six placentas collected from normal pregnant females tested negative for SARS-CoV-2, which showed no signs or signals for infection whatsoever. On the other hand, in these 23 specimens we further found that ACSL4 expression levels were significantly increased compared with those of six negative counterparts, and correlation analysis revealed a positive trend existing between staining degree of PSS and ACSL4. As a result, our study not only provides robust evidence for capacity possessed by SARS-CoV-2 virions to infect human placenta, but also supports that ferroptosis is activated in the response to this viral infection.
Our study has shown that SARS-CoV-2 can function as a potent trigger for activation of ferroptosis in human placenta. A variety of infectious agents including viruses can influence production of reactive oxygen species, iron metabolism and transport, and antioxidative defenses to a substantially great scope (). Patients with COVID-19 demonstrated higher serum ferritin levels, consistent with an elevated iron exposure in tissues (). In addition, lipids alteration and induction of transferrin receptor, another well investigated and specific biomarker for ferroptosis (), have been reported in Syrian golden hamsters following a challenge by of SARS-CoV-2 virions (). ACSL4, typical marker of ferroptosis owing to its capability to preferentially activate long-chain polyunsaturated fatty acids (PUFAs) for phospholipid biosynthesis and fueling ferroptotic process, has been considered as the major determinant for dictating ferroptosis sensitivity and reshaping cellular lipid composition (), which are highly susceptible to peroxidation because of the presence of extraordinarily weak C-H bonds existing between adjacent C=C double bonds (). Mechanistically, by virtue of its role in facilitating incorporation of PUFAs into membrane lipids, ACSL4 is also capable of amplifying the ferroptosis process in a feed-forward mechanism characterized with the loop of protein kinase C beta 2-phosphorylated ACSL4 (). To this end, ACSL4 is unanimously deemed as an essential executioner of ferroptosis, comparable to the role of caspase-3 as in apoptosis.
Placental susceptibility to ferroptosis highlights a key role of a major cascade of molecular events linking initiation of a pathophysiological condition resulting from SARS-CoV-2 crossing of the placental barrier to ultimate manifestations of pregnancy-related sequalae. Indeed, human placenta can produce a wide array of hormones and cytokines, such as human chorionic gonadotropin and progesterone, to sustain pregnancy, and therefore, placental dysfunction largely accounts for pathogenesis of most adverse pregnancy outcomes. A recent systematic review and meta-analysis on the impact of COVID-19 on pregnancy outcomes involving 42 studies and 438,538 patients concluded that SARS-CoV-2 infection is closely associated with risks of hypertension disorders of pregnancy, intrauterine fetal demise, and preterm birth (). In addition, SARS-CoV-2 infection has been shown to be associated with spontaneous abortion in a cohort study of 3,041 pregnancies conducted in the United Kingdom (). Nonetheless, elevated levels of oxidative stress and subsequent accumulation of reactive oxygen species and lipid peroxidation have been frequently implicated in placental insufficiency and related diseases (; ). An excessive accumulation of hydroperoxy-arachidonoyl (C20:4)- or adrenoyl (C22:4)- phosphatidylethanolamine (Hp-PE) characterizes ferroptotic cell death, and ferroptosis proceeds when Hp-PE levels exceed cellular defense (; ). By using mass spectrometry-based phospholipidomics analysis, a recent study by Beharier and others has found that preterm birth-associated injured placentas exhibited augmented levels of Hp-PE (). Combined with these published studies, our study further supports that the role of ferroptosis in molecularly connecting SARS-CoV-2 infection and adverse obstetrical outcomes deserves further investigations.
Some limitations are associated with this study. Because of limited sample size, we were not able to reach a conclusion with respect to a significant trend positively correlating the degree of placental SARS-CoV-2 infection and scopes of ferroptosis activation. Furthermore, the lack of in vitro including use of primary cytotrophoblast as the model as well as in vivo animal studies makes it difficult to establish a definitive causal relationship. However, these experiments will be included in our future directions.
In summary, this study has uncovered that SARS-CoV-2 infection may activate ferroptosis in the human placenta. Thus, pregnant females diagnosed with COVID-19 need to be considered at high risks for adverse clinical outcomes and should be included in all preventive strategies. Moreover, our study provides opportunities to ultimately control and manage adverse pregnancy-related outcomes, which can be facilitated by development of potent and selective chemical compounds and biologics based on specifically targeting markers characteristics of ferroptosis in the placenta. As such, ferroptosis inhibition could constitute a viable strategy to prevent placental injury and insufficiency due to viral infection in the clinical care setting.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material further inquiries can be directed to the corresponding authors.
Ethics statement
The studies involving human participants were reviewed and approved by The Institutional Review Board of the University of Maryland, Baltimore, under the protocols HP-00091334 and HP-00100457. The patients/participants provided their written informed consent to participate in this study.
Author contributions
BW, PY, and ST conceived the study. BW and W-BS performed experiments. BW, PY, and ST analyzed and interpreted data, and drafted and edited the manuscript. All authors have reviewed and approved the article.
Funding
This study was supported by a departmental D01 grant to BW and ST, and by National Institutes of Health grants (R01HL139060, R01HL153141, and R01HL151108) to PY.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AlbercaR. W.PereiraN. Z.OliveiraL.Gozzi-SilvaS. C.SatoM. N. (2020). Pregnancy, viral infection, and COVID-19. Front. Immunol.11, 1672. 10.3389/fimmu.2020.01672
2
AnthonymuthuT. S.KennyE. M.ShrivastavaI.TyurinaY. Y.HierZ. E.TingH. C.et al (2018). Empowerment of 15-lipoxygenase catalytic competence in selective oxidation of membrane ETE-PE to ferroptotic death signals, HpETE-PE. J. Am. Chem. Soc.140, 17835–17839. 10.1021/jacs.8b09913
3
BalachandrenN.DaviesM. C.HallJ. A.StephensonJ. M.DavidA. L.BarrettG.et al (2022). SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: A UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic. Hum. Reprod.37, 1126–1133. 10.1093/humrep/deac062
4
BankheadP.LoughreyM. B.FernandezJ. A.DombrowskiY.McartD. G.DunneP. D.et al (2017). QuPath: Open source software for digital pathology image analysis. Sci. Rep.7, 16878. 10.1038/s41598-017-17204-5
5
BednashJ. S.KaganV. E.EnglertJ. A.FarkasD.TyurinaY. Y.TyurinV. A.et al (2022). Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling. Transl. Res.240, 1–16. 10.1016/j.trsl.2021.10.007
6
BeharierO.KajiwaraK.SadovskyY. (2021). Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome. Placenta108, 32–38. 10.1016/j.placenta.2021.03.007
7
BeharierO.TyurinV. A.GoffJ. P.Guerrero-SantoroJ.KajiwaraK.ChuT.et al (2020). PLA2G6 guards placental trophoblasts against ferroptotic injury. Proc. Natl. Acad. Sci. U. S. A.117, 27319–27328. 10.1073/pnas.2009201117
8
CavezziA.MenicagliR.TroianiE.CorraoS. (2022). COVID-19, cation dysmetabolism, sialic acid, CD147, ACE2, viroporins, hepcidin and ferroptosis: A possible unifying hypothesis. F1000Res.11, 102. 10.12688/f1000research.108667.2
9
CavezziA.TroianiE.CorraoS. (2020). COVID-19: Hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin. Pract.10, 1271. 10.4081/cp.2020.1271
10
DixonS. J.LembergK. M.LamprechtM. R.SkoutaR.ZaitsevE. M.GleasonC. E.et al (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell.149, 1060–1072. 10.1016/j.cell.2012.03.042
11
DollS.PronethB.TyurinaY. Y.PanziliusE.KobayashiS.IngoldI.et al (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol.13, 91–98. 10.1038/nchembio.2239
12
DubucsC.GroussollesM.OusselinJ.SartorA.Van AckerN.VayssiereC.et al (2022). Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death. Hum. Pathol.121, 46–55. 10.1016/j.humpath.2021.12.012
13
EdeasM.SalehJ.PeyssonnauxC. (2020). Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?Int. J. Infect. Dis.97, 303–305. 10.1016/j.ijid.2020.05.110
14
FengH.SchorppK.JinJ.YozwiakC. E.HoffstromB. G.DeckerA. M.et al (2020). Transferrin receptor is a specific ferroptosis marker. Cell. Rep.30, 3411–3423. 10.1016/j.celrep.2020.02.049
15
Fratta PasiniA. M.StranieriC.GirelliD.BustiF.CominaciniL. (2021). Is ferroptosis a key component of the process leading to multiorgan damage in COVID-19?Antioxidants (Basel)10, 1677. 10.3390/antiox10111677
16
Ganor PazY.ShilohS.Brosh-NissimovT.GrupelD.SorekN.KustinT.et al (2021). The association between SARS-CoV-2 infection and late pregnancy loss. Int. J. Gynaecol. Obstet.157, 208–209. 10.1002/ijgo.14025
17
GarovicV. D.WhiteW. M.VaughanL.SaikiM.ParashuramS.Garcia-ValenciaO.et al (2020). Incidence and long-term outcomes of hypertensive disorders of pregnancy. J. Am. Coll. Cardiol.75, 2323–2334. 10.1016/j.jacc.2020.03.028
18
GiesbersS.GohE.KewT.AlloteyJ.BrizuelaV.KaraE.et al (2021). Treatment of COVID-19 in pregnant women: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol.267, 120–128. 10.1016/j.ejogrb.2021.10.007
19
HabibH. M.IbrahimS.ZaimA.IbrahimW. H. (2021). The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed. Pharmacother.136, 111228. 10.1016/j.biopha.2021.111228
20
IlekisJ. V.TsilouE.FisherS.AbrahamsV. M.SoaresM. J.CrossJ. C.et al (2016). Placental origins of adverse pregnancy outcomes: Potential molecular targets: An executive Workshop summary of the eunice kennedy shriver national institute of child Health and human development. Am. J. Obstet. Gynecol.215, S1–S46. 10.1016/j.ajog.2016.03.001
21
JiangX.StockwellB. R.ConradM. (2021). Ferroptosis: Mechanisms, biology and role in disease. Nat. Rev. Mol. Cell. Biol.22, 266–282. 10.1038/s41580-020-00324-8
22
KaganV. E.MaoG.QuF.AngeliJ. P.DollS.CroixC. S.et al (2017). Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol.13, 81–90. 10.1038/nchembio.2238
23
KaushalK.KaurH.SarmaP.BhattacharyyaA.SharmaD. J.PrajapatM.et al (2022). Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J. Crit. Care67, 172–181. 10.1016/j.jcrc.2021.09.023
24
Lane-CordovaA. D.KhanS. S.GrobmanW. A.GreenlandP.ShahS. J. (2019). Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week. J. Am. Coll. Cardiol.73, 2106–2116. 10.1016/j.jacc.2018.12.092
25
LiuJ.BabkaA. M.KearneyB. J.RadoshitzkyS. R.KuhnJ. H.ZengX. (2020). Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens. JCI Insight5, 139042. 10.1172/jci.insight.139042
26
NarangK.EnningaE. a. L.GunaratneM.IbirogbaE. R.TradA. T. A.ElrefaeiA.et al (2020). SARS-CoV-2 infection and COVID-19 during pregnancy: A multidisciplinary review. Mayo Clin. Proc.95, 1750–1765. 10.1016/j.mayocp.2020.05.011
27
PapageorghiouA. T.DeruelleP.GunierR. B.RauchS.Garcia-MayP. K.MhatreM.et al (2021). Preeclampsia and COVID-19: Results from the INTERCOVID prospective longitudinal study. Am. J. Obstet. Gynecol.225, 289.e1–289289.e17. 10.1016/j.ajog.2021.05.014
28
RobertsD. J.EdlowA. G.RomeroR. J.CoyneC. B.TingD. T.HornickJ. L.et al (2021). National Institutes of health/eunice kennedy shriver national institute of child, H., and human development, S.-C.-P.I.WA standardized definition of placental infection by SARS-CoV-2, a consensus statement from the national Institutes of health/eunice kennedy shriver national institute of child Health and human development SARS-CoV-2 placental infection Workshop. Am. J. Obstet. Gynecol.225, 593–599.e2. 10.1016/j.ajog.2021.07.029
29
RotondoJ. C.MartiniF.MaritatiM.CaselliE.GallengaC. E.GuarinoM.et al (2022). Advanced molecular and immunological diagnostic methods to detect SARS-CoV-2 infection. Microorganisms10, 1193. 10.3390/microorganisms10061193
30
SchneiderC. A.RasbandW. S.EliceiriK. W. (2012). NIH image to ImageJ: 25 years of image analysis. Nat. Methods9, 671–675. 10.1038/nmeth.2089
31
SchootsM. H.GordijnS. J.ScherjonS. A.Van GoorH.HillebrandsJ. L. (2018). Oxidative stress in placental pathology. Placenta69, 153–161. 10.1016/j.placenta.2018.03.003
32
SchwartzD. A.MorottiD. (2020). Placental pathology of COVID-19 with and without fetal and neonatal infection: Trophoblast necrosis and chronic histiocytic intervillositis as risk factors for transplacental transmission of SARS-CoV-2. Viruses12, E1308. 10.3390/v12111308
33
ShenW. B.NiJ.YaoR.GoetzingerK. R.HarmanC.ReeceE. A.et al (2022a). Maternal obesity increases DNA methylation and decreases RNA methylation in the human placenta. Reprod. Toxicol.107, 90–96. 10.1016/j.reprotox.2021.12.002
34
ShenW. B.TuranS.WangB.CojocaruL.HarmanC.LogueJ.et al (2022b). A SARS-CoV-2 delta variant case manifesting as extensive placental infection and fetal transmission. Gynecol. Obstet. Invest..87, 165–172. 10.1159/000524905
35
SmithD. R.ShoemakerC. J.ZengX.GarrisonA. R.GoldenJ. W.SchellhaseC. W.et al (2019). Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog.15, e1008050. 10.1371/journal.ppat.1008050
36
StockwellB. R. (2022). Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell.185, 2401–2421. 10.1016/j.cell.2022.06.003
37
StockwellB. R.Friedmann AngeliJ. P.BayirH.BushA. I.ConradM.DixonS. J.et al (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell.171, 273–285. 10.1016/j.cell.2017.09.021
38
Van Der EijkA. A.Van GenderenP. J.VerdijkR. M.ReuskenC. B.MoglingR.Van KampenJ. J.et al (2016). Miscarriage associated with zika virus infection. N. Engl. J. Med.375, 1002–1004. 10.1056/NEJMc1605898
39
WangF.FlanaganJ.SuN.WangL. C.BuiS.NielsonA.et al (2012). RNAscope: A novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn.14, 22–29. 10.1016/j.jmoldx.2011.08.002
40
WeiS. Q.Bilodeau-BertrandM.LiuS.AugerN. (2021). The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis. CMAJ193, E540–E548. 10.1503/cmaj.202604
41
YaoR.YangP.GoetzingerK. R.AtkinsK. L.ShenW. B.WangB.et al (2022). Maternal obesity-associated disruption of polarized lactate transporter MCT4 expression in human placenta. Reprod. Toxicol.112, 1–6. 10.1016/j.reprotox.2022.06.009
42
YuanH.LiX.ZhangX.KangR.TangD. (2016). Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem. Biophys. Res. Commun.478, 1338–1343. 10.1016/j.bbrc.2016.08.124
43
ZhangH.HeY.WangJ. X.ChenM. H.XuJ. J.JiangM. H.et al (2020). miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia. Redox Biol.29, 101402. 10.1016/j.redox.2019.101402
44
ZhangH. L.HuB. X.LiZ. L.DuT.ShanJ. L.YeZ. P.et al (2022). PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat. Cell. Biol.24, 88–98. 10.1038/s41556-021-00818-3
Summary
Keywords
SARS-CoV-2, positive-sense strand, ferroptosis, ACSL4, placenta, adverse pregnancy outcomes
Citation
Wang B, Shen W-B, Yang P and Turan S (2022) SARS-CoV-2 infection induces activation of ferroptosis in human placenta. Front. Cell Dev. Biol. 10:1022747. doi: 10.3389/fcell.2022.1022747
Received
18 August 2022
Accepted
27 October 2022
Published
08 November 2022
Volume
10 - 2022
Edited by
Athina Samara, Karolinska Institutet (KI), Sweden
Reviewed by
Emidio Troiani, Ospedale di Stato della Repubblica di San Marino, San Marino
John Charles Rotondo, University of Ferrara, Italy
Updates
Copyright
© 2022 Wang, Shen, Yang and Turan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bingbing Wang, bwang@som.umaryland.edu; Peixin Yang, pyang@som.umaryland.edu; Sifa Turan, sturan@som.umaryland.edu
This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.